In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain
- 1 March 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (3) , 892-895
- https://doi.org/10.1128/aac.46.3.892-895.2002
Abstract
The antimicrobial activities of tigecycline (GAR-936) were compared with those of other agents against 1,087 strains recently isolated in 12 Spanish medical centers. Tigecycline showed activity against a wide spectrum of aerobic and anaerobic bacteria, including strains such as methicillin-resistant Staphylococcus aureus , coagulase-negative staphylococci, penicillin-resistant Streptococcus pneumoniae , Enterococcus faecium , Acinetobacter baumannii , and Stenotrophomonas maltophilia.Keywords
This publication has 18 references indexed in Scilit:
- Clinical Prevalence, Antimicrobial Susceptibility, and Geographic Resistance Patterns of Enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas , and Peptostreptococcus SpeciesAntimicrobial Agents and Chemotherapy, 2001
- Epidemiological, Microbiological, Clinical, and Prognostic Factors of Bacteremia Caused by High-Level Vancomycin-Resistant Enterococcus SpeciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 2000
- In-vitro susceptibility of anaerobic bacteria to gar-936, a new glycylcyclineClinical Microbiology & Infection, 2000
- Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in CanadaNew England Journal of Medicine, 1999
- Geographical distribution of quinolone resistance among Staphylococcus aureus, Escherichia coli and Klebsiella spp. isolates from 20 European university hospitalsJournal of Antimicrobial Chemotherapy, 1999
- N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocciAntimicrobial Agents and Chemotherapy, 1994
- Changes in the susceptibility ofBacteroides fragilis group organisms to various antimicrobial agents 1979–1989European Journal of Clinical Microbiology & Infectious Diseases, 1992
- Resistance of Anaerobic Bacteria to Antimicrobial AgentsClinical Infectious Diseases, 1990